<DOC>
	<DOCNO>NCT02500342</DOCNO>
	<brief_summary>Thyroid hormone key regulatory hormone range physiological system . An impaired function thyroid gland subclinical hypothyroidism ( SCH ) affect quality life . Older adult subclinical hypothyroidism often report non-specific symptom tiredness . In addition , muscle symptom cramp , weakness myalgia common SCH healthy control . At present , evidence lack benefit thyroxine replacement elderly SCH , large randomize clinical trial ( RCT ) full range relevant clinical outcome , include tiredness perform . Moreover , continue uncertainty long-term impact health relate quality life thyroxine treatment SCH . The aim study examine , within large RCT elderly participant subclinical hypothyroidism , impact thyroxine therapy association subclinical thyroid disease ( SCTD ) level physical mental fatigue . The exist trial infrastructure ( TRUST thyroid trial-Euresearch FP7 ; clinicaltrials.gov ID : NCT 01660126 ) utilized collect information level physical mental fatigue use Pittsburgh Fatigability Scale baseline 1 year 220 participant persistent subclinical hypothyroidism randomize either thyroxine placebo .</brief_summary>
	<brief_title>Effect Thyroid Hormone Replacement Fatigability Untreated Older Adults With Subclinical Hypothyroidism</brief_title>
	<detailed_description>Background Thyroid hormone key regulatory hormone range physiological system . An impaired function thyroid gland subclinical hypothyroidism ( SCH ) affect quality life . Older adult subclinical hypothyroidism often report non-specific symptom tiredness . In addition , muscle symptom cramp , weakness myalgia common SCH healthy control . At present , evidence lack benefit thyroxine replacement elderly SCH , large randomize clinical trial ( RCT ) full range relevant clinical outcome , include tiredness perform . Moreover , continue uncertainty long-term impact health relate quality life thyroxine treatment SCH . Objective To examine , within large RCT elderly participant subclinical hypothyroidism ( TRUST trial ) , impact thyroxine therapy association subclinical thyroid disease ( SCTD ) level physical mental fatigue . Methods The exist trial infrastructure ( TRUST thyroid trial-Euresearch FP7 , clinicaltrials.gov ID : NCT 01660126 ) utilized collect information level physical mental fatigue use Pittsburgh Fatigability Scale baseline 1 year 220 participant persistent subclinical hypothyroidism randomize either thyroxine placebo .</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Mental Fatigue</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Communitydwelling patient age &gt; = 65 year subclinical hypothyroidism Written inform consent Exclusion Criteria Subjects currently Levothyroxine antithyroid drug ( amiodarone , lithium ) Recent thyroid surgery radioiodine ( within 12 month ) Grade IV NYHA heart failure Prior clinical diagnosis dementia Recent hospitalization major illness elective surgery ( within 4 week ) Terminal illness Patients rare hereditary problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption Subjects participate ongoing RCTs therapeutic intervention ( include CTIMPs ) Plan move region trial conduct within next 2 year ( propose minimum followup period )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Thyroid Dysfunction</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Thyroxine</keyword>
	<keyword>Hypothyroidism</keyword>
</DOC>